Table of Contents

1 Study Coverage

• 1.1 Demerol (Meperidine) Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Demerol (Meperidine) Market Size Growth Rate by Product
  • 1.4.2 Powder
  • 1.4.3 Liquid
• 1.5 Market by End User
  • 1.5.1 Global Demerol (Meperidine) Market Size Growth Rate by End User
  • 1.5.2 Anesthesia
  • 1.5.3 Cough Treatment
  • 1.5.4 Diarrhea Treatment
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Demerol (Meperidine) Market Size
  • 2.1.1 Global Demerol (Meperidine) Revenue 2014-2025
  • 2.1.2 Global Demerol (Meperidine) Sales 2014-2025
• 2.2 Demerol (Meperidine) Growth Rate by Regions
  • 2.2.1 Global Demerol (Meperidine) Sales by Regions
  • 2.2.2 Global Demerol (Meperidine) Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Demerol (Meperidine) Sales by Manufacturers
  • 3.1.1 Demerol (Meperidine) Sales by Manufacturers
  • 3.1.2 Demerol (Meperidine) Sales Market Share by Manufacturers
  • 3.1.3 Global Demerol (Meperidine) Market Concentration Ratio (CR5 and HHI)
• 3.2 Demerol (Meperidine) Revenue by Manufacturers
  • 3.2.1 Demerol (Meperidine) Revenue by Manufacturers (2014-2019)
  • 3.2.2 Demerol (Meperidine) Revenue Share by Manufacturers (2014-2019)
• 3.3 Demerol (Meperidine) Price by Manufacturers
• 3.4 Demerol (Meperidine) Manufacturing Base Distribution, Product Types
  • 3.4.1 Demerol (Meperidine) Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Demerol (Meperidine) Product Type
  • 3.4.3 Date of International Manufacturers Enter into Demerol (Meperidine) Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Demerol (Meperidine) Sales by Product
• 4.2 Global Demerol (Meperidine) Revenue by Product
• 4.3 Demerol (Meperidine) Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Demerol (Meperidine) Breakdown Data by End User

6 North America

• 6.1 North America Demerol (Meperidine) by Countries
  • 6.1.1 North America Demerol (Meperidine) Sales by Countries
  • 6.1.2 North America Demerol (Meperidine) Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Demerol (Meperidine) by Product
• 6.3 North America Demerol (Meperidine) by End User

7 Europe

• 7.1 Europe Demerol (Meperidine) by Countries
  • 7.1.1 Europe Demerol (Meperidine) Sales by Countries
  • 7.1.2 Europe Demerol (Meperidine) Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Demerol (Meperidine) by Product
• 7.3 Europe Demerol (Meperidine) by End User

8 Asia Pacific

• 8.1 Asia Pacific Demerol (Meperidine) by Countries
  • 8.1.1 Asia Pacific Demerol (Meperidine) Sales by Countries
  • 8.1.2 Asia Pacific Demerol (Meperidine) Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Demerol (Meperidine) by Product
• 8.3 Asia Pacific Demerol (Meperidine) by End User

9 Central & South America

• 9.1 Central & South America Demerol (Meperidine) by Countries
  • 9.1.1 Central & South America Demerol (Meperidine) Sales by Countries
  • 9.1.2 Central & South America Demerol (Meperidine) Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Demerol (Meperidine) by Product
• 9.3 Central & South America Demerol (Meperidine) by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Demerol (Meperidine) by Countries
  • 10.1.1 Middle East and Africa Demerol (Meperidine) Sales by Countries
  • 10.1.2 Middle East and Africa Demerol (Meperidine) Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Demerol (Meperidine) by Product
• 10.3 Middle East and Africa Demerol (Meperidine) by End User

11 Company Profiles

• 11.1 Purdue Pharma
  • 11.1.1 Purdue Pharma Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 Purdue Pharma Demerol (Meperidine) Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 Purdue Pharma Demerol (Meperidine) Products Offered
  • 11.1.5 Purdue Pharma Recent Development
• 11.2 Egalet
  • 11.2.1 Egalet Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 Egalet Demerol (Meperidine) Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 Egalet Demerol (Meperidine) Products Offered
  • 11.2.5 Egalet Recent Development
• 11.3 Boehringer Ingelheim
  • 11.3.1 Boehringer Ingelheim Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 Boehringer Ingelheim Demerol (Meperidine) Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 Boehringer Ingelheim Demerol (Meperidine) Products Offered
  • 11.3.5 Boehringer Ingelheim Recent Development
• 11.4 Janssen
  • 11.4.1 Janssen Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 Janssen Demerol (Meperidine) Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 Janssen Demerol (Meperidine) Products Offered
  • 11.4.5 Janssen Recent Development
• 11.5 Sanofi
  • 11.5.1 Sanofi Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 Sanofi Demerol (Meperidine) Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 Sanofi Demerol (Meperidine) Products Offered
  • 11.5.5 Sanofi Recent Development
• 11.6 Sun Pharmaceuticals
  • 11.6.1 Sun Pharmaceuticals Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 Sun Pharmaceuticals Demerol (Meperidine) Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 Sun Pharmaceuticals Demerol (Meperidine) Products Offered
  • 11.6.5 Sun Pharmaceuticals Recent Development
• 11.7 Mallinckrodt Pharmaceuticals
  • 11.7.1 Mallinckrodt Pharmaceuticals Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 Mallinckrodt Pharmaceuticals Demerol (Meperidine) Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 Mallinckrodt Pharmaceuticals Demerol (Meperidine) Products Offered
  • 11.7.5 Mallinckrodt Pharmaceuticals Recent Development
• 11.8 Endo Pharmaceuticals
  • 11.8.1 Endo Pharmaceuticals Company Details
  • 11.8.2 Company Business Overview
  • 11.8.3 Endo Pharmaceuticals Demerol (Meperidine) Sales, Revenue and Gross Margin (2014-2019)
  • 11.8.4 Endo Pharmaceuticals Demerol (Meperidine) Products Offered
  • 11.8.5 Endo Pharmaceuticals Recent Development
• 11.9 Actavis
  • 11.9.1 Actavis Company Details
  • 11.9.2 Company Business Overview
  • 11.9.3 Actavis Demerol (Meperidine) Sales, Revenue and Gross Margin (2014-2019)
  • 11.9.4 Actavis Demerol (Meperidine) Products Offered
  • 11.9.5 Actavis Recent Development
• 11.10 Pfizer
  • 11.10.1 Pfizer Company Details
  • 11.10.2 Company Business Overview
  • 11.10.3 Pfizer Demerol (Meperidine) Sales, Revenue and Gross Margin (2014-2019)
  • 11.10.4 Pfizer Demerol (Meperidine) Products Offered
  • 11.10.5 Pfizer Recent Development

12 Future Forecast

• 12.1 Demerol (Meperidine) Market Forecast by Regions
  • 12.1.1 Global Demerol (Meperidine) Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Demerol (Meperidine) Revenue Forecast by Regions 2019-2025
• 12.2 Demerol (Meperidine) Market Forecast by Product
  • 12.2.1 Global Demerol (Meperidine) Sales Forecast by Product 2019-2025
  • 12.2.2 Global Demerol (Meperidine) Revenue Forecast by Product 2019-2025
• 12.3 Demerol (Meperidine) Market Forecast by End User
• 12.4 North America Demerol (Meperidine) Forecast
• 12.5 Europe Demerol (Meperidine) Forecast
• 12.6 Asia Pacific Demerol (Meperidine) Forecast
• 12.7 Central & South America Demerol (Meperidine) Forecast
• 12.8 Middle East and Africa Demerol (Meperidine) Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Demerol (Meperidine) Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details

Demerol (meperidine), chemically known as ethyl 1-methyl-4-phenylisonipecotate hydrochloride, is an opioid pain medication. Meperidine is used to treat moderate-to-severe pain.
An opioid is sometimes referred to as narcotics. Opioids are drugs that act on the nervous system to relieve pain. The term opioid refers to all substances (exogenous or endogenous) with morphine-like properties.
The global Demerol (Meperidine) market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Demerol (Meperidine) market based on company, product type, end user and key regions.

This report studies the global market size of Demerol (Meperidine) in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Demerol (Meperidine) in these regions.
This research report categorizes the global Demerol (Meperidine) market by top players/brands, region, type and end user. This report also studies the global Demerol (Meperidine) market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Purdue Pharma
Egalet
Boehringer Ingelheim
Janssen
Sanofi
Sun Pharmaceuticals
Mallinckrodt Pharmaceuticals
Endo Pharmaceuticals
Actavis
Pfizer

Market size by Product
Powder
Liquid
Market size by End User
Anesthesia
Cough Treatment
Diarrhea Treatment

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Demerol (Meperidine) market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Demerol (Meperidine) market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Demerol (Meperidine) companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Demerol (Meperidine) submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Demerol (Meperidine) are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Demerol (Meperidine) market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.